Literature DB >> 315921

Immunoglobulin synthesis by thymus B cells.

P Jentz, C T Chou, I Szymanska, R R Alcala, A S Dubiski, B Cinader.   

Abstract

Rabbit lymphoid cells transferred to newborn recipients synthesized donor-type immunoglobulin. Elimination of donor T cells did not affect this synthesis of donor immunoglobulin, while elimination of B cells abolished or significantly decreased the synthesis. The synthetic capacity of B cells from thymus was thirty-four times greater than the synthetic capacities of B cells from spleen, fifty-five times greater than that of mesenteric lymph nodes and 180 times greater than that of appendix cells. Synthetic activity of spleen cells ceased before the tenth day after transfer, while thymus cells might continue to synthesize immunoglobulin for a longer time. This was shown by comparing half-lives of donor immunoglobulin in the recipients' sera. Increasing the number of injected spleen cells (from 2 x 10(6) to 120 x 10(6)), resulted in a corresponding increase in donor Ig synthesis. With thymus cells, donor immunoglobulin increased with cell numbers up to 2 x 10(7) cells, above this dose there was no further donor immunoglobulin increase in the recipients' serum.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315921      PMCID: PMC1457940     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  A DIALYSIS TECHNIQUE FOR PREPARING FLUORESCENT ANTIBODY.

Authors:  H F CLARK; C C SHEPARD
Journal:  Virology       Date:  1963-08       Impact factor: 3.616

2.  IMMUNE LYSIS OF THYMUS AND SPLEEN CELLS OF EMBRYONIC AND NEONATAL MICE.

Authors:  M SCHLESINGER
Journal:  J Immunol       Date:  1965-03       Impact factor: 5.422

3.  Micromethods for the study of proteins and antibodies. III. Procedures and applications of hemagglutination and hemagglutination-inhibition reactions with bis-diazotized benzidine and protein-conjugated red blood cells.

Authors:  A B STAVITSKY; E R ARQUILLA
Journal:  J Immunol       Date:  1955-04       Impact factor: 5.422

4.  Long-term immunoglobulin G production by transplanted thymus cells.

Authors:  H S Micklem; N Anderson; J Ure; H P Jones
Journal:  Eur J Immunol       Date:  1976-06       Impact factor: 5.532

5.  Effect of cyclic nucleotides, isoproterenol and cholera toxin on DNA synthesis triggered by mitogens.

Authors:  M Emin; S Dubiski; B Cinader
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

6.  Antibody formation and experimentally induced chimerism in very young rabbits.

Authors:  C T Chou; S Dubiski; B Cinader
Journal:  Nature       Date:  1966-07-02       Impact factor: 49.962

7.  Regulatory influences on the response of rabbit T cells to concanavalin A and phytohaemagglutinin.

Authors:  A R Rivas Alcala; C T Chou; B Cinader; S Dubiski; M F Filosa
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

8.  Immunocompetent cells among mouse thymocytes: a minor population.

Authors:  E Leckband; E A Boyse
Journal:  Science       Date:  1971-06-18       Impact factor: 47.728

9.  Stable chimerism induced in noninbred rabbits by neonatal injection of spleen cells from alltoype-suppressed adult donors. II. Distribution of donor and recipient allotypes on blood lymphocytes, in serum immunoglobulins, and in specific antibodies.

Authors:  L T Adler; F L Adler; A Yamada
Journal:  Transplantation       Date:  1978-12       Impact factor: 4.939

10.  Cells as antigen carriers and as immunoglobulin producers. Synthesis of antibody and allogeneic immunoglobulin after transfer of antigen-treated cells to newborn rabbits.

Authors:  C T Chou; S Dubiski; B Cinader
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

View more
  1 in total

1.  Ontogeny and characterization of mitogen-reactive lymphocytes in the thymus and spleen of the amphibian, Xenopus laevis.

Authors:  N H Williams; F A Cribbin; L D Zettergren; J D Horton
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.